Cardiovascular Devices Market By Type of Device (Diagnostic Devices (ECG, Holter Monitors, Echocardiography, MRI, CT Scanners); Therapeutic Devices (Pacemakers, Defibrillators, Stents, Heart Valves, Catheters, TAVR Systems)); By Application (Cardiac Surgery, Diagnostic Imaging, Coronary Artery Disease (CAD), Heart Valve Diseases, Arrhythmia); By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Cardiology Clinics, Home Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Cardiovascular Devices Market: Advancing Cardiac Healthcare and Innovation

The global cardiovascular devices market was valued at approximately $54.1billion in 2023 and is projected to reach $88.2 billion by 2030, growing at a CAGR of 6.9% (2024-2030). The increasing prevalence of cardiovascular diseases (CVDs), advancements in medical technology, & the increasing adoption of minimally invasive procedures are key factors driving market growth.

 

The U.S. Cardiovascular Devices Market is the largest globally, driven by high healthcare spending, advanced medical infrastructure, and a rising prevalence of cardiovascular diseases (CVDs). Valued at approximately $21 billion in 2024, the market is expected to grow at a CAGR of 5.7%, fueled by increasing demand for minimally invasive procedures, AI-powered diagnostics, and remote cardiac monitoring solutions. The U.S. has a strong regulatory framework, with the FDA approving innovative cardiovascular devices such as leadless pacemakers and bioresorbable stents. Additionally, the rise in telehealth and wearable cardiac monitors, such as Apple Watch ECG and Medtronic's LINQ II implantable monitor, is enhancing early diagnosis and remote patient management, further driving market expansion.

 

The market encompasses a wide range of devices which includes pacemakers, stents, heart valves, monitoring systems, and implantable cardioverter defibrillators (ICDs). North America holds the largest market share due to the presence of well-established healthcare infrastructure & high adoption of advanced cardiac technologies, while the APAC region is expected to witness the fastest growth, driven by improving healthcare access and increasing government investments in cardiac care. With the expansion of remote patient monitoring & AI-driven diagnostic solutions, the cardiovascular devices market is poised for sustained growth, addressing the increasing global burden of heart diseases.

 

Cardiovascular Devices Market Dynamics: Enhancing Cardiac Care

Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The 2025 Heart Disease and Stroke Statistics Update from the American Heart Association indicates that heart disease continues to be the leading cause of death in the United States. The rising incidence of hypertension and obesity has led to an increased demand for diagnostic & therapeutic cardiovascular devices. According to a recent report from the World Heart Federation (WHF), the number of global deaths due to cardiovascular disease (CVD) surged from 12.1 Mn in 1990 to 20.5 Mn in 2021. In 2021, CVD remained the leading cause of death worldwide, with 80% of these fatalities occurring in low- and middle-income countries (LMICs). The highest CVD death rates occur in the Central Europe, Eastern Europe & Central Asia region.

Technological Advancements in Cardiac Devices

Continuous innovations in medical technology, including AI-powered diagnostic tools, remote patient monitoring (RPM), and biodegradable stents, are revolutionizing cardiac care. In 2023, researchers tested the “world’s smallest heart pump,” the Elevate™ Percutaneous Left Ventricular Assist Device. Two participants in New York were the first patients in an FDA-approved “Early Feasibility Study.” Magenta Medical developed the Elevate™ system to support circulation mechanically during high-risk percutaneous coronary intervention procedures. In 2023, researchers at Ohio State University initiated a 2-year trial with 500 chronic heart failure patients to develop the HearO app.1 HearO tracks the nuances of a patient’s speech patterns to detect signs of heart failure.

 

Market Opportunities

Growth in Home-Based and Wearable Cardiac Monitoring

The shift toward remote cardiac monitoring and wearables, such as smartwatches with ECG capabilities, is creating new market opportunities. Remote monitoring & control of heart function are of primary importance for patient evaluation & management, especially in the modern era of precision medicine & personalized approaches. The wearable cardiac device market is projected to expand at a CAGR of 9.2% over the next five years. Smartwatches and wristbands are the most popular type of wearable devices, holding the dominant share of the global market, with a projected CAGR of 20% until 2026. Apple Watch Series 8 and Fitbit Sense provide real-time ECG monitoring, improving early detection of arrhythmias. Many other companies have also launched smartwatches capable of heart rhythm detection, using either a PPG sensor or a combination of PPG and single-lead ECG.

Expansion in Emerging Markets

Rapid urbanization, increasing healthcare investments, and improved access to cardiac care in Asia-Pacific, Latin America, and the Middle East are driving demand for cardiovascular devices. In numerous emerging markets, local medical technology companies receive both direct and indirect assistance from the government throughout the entire value chain. This support often includes subsidized research and development, expedited regulatory approvals, tax and financial incentives, encouragement for domestic sourcing, and favorable reimbursement policies for local companies. India’s Ayushman Bharat initiative is expanding healthcare access, increasing demand for cardiac diagnostic and surgical devices.

 

Market Challenges

High Cost of Cardiovascular Procedures and Devices

Cardiovascular-related hospitalizations, procedural utilization, and health care costs in the United States represent a high burden demonstrating upward trends across the past several years, according to study findings published in The American Journal of Cardiology. In 2021, annual health care spending in the United States (US) increased by 2.7% to $4.3 trillion or $12,914 per person. Advanced cardiac devices, such as implantable cardioverter-defibrillators (ICDs) and transcatheter aortic valve replacement (TAVR) devices, are expensive, limiting accessibility. The average cost of a pacemaker implantation in the U.S. ranges from $20,000 to $50,000.

Stringent Regulatory Approvals

Regulatory challenges, including FDA approvals and EU MDR compliance, create barriers for new device launches. The EU MDR regulations have delayed market entry for several medical devices, impacting manufacturers. The PMA regulatory process strictly reviews & assesses the safety & effectiveness of Class III medical devices. General & Special control regulatory processes were deemed insufficient by the FDA for Class III medical devices. The regulations that are involved in the PMA regulatory process are provided in 21 CFR part 814, Premarket Approval of Medical Devices.

 

Cardiovascular Devices Market Segmentation: A Comprehensive Overview

By Type of Device

• Diagnostic Devices

  • ECG

  • Holter Monitors

  • Echocardiography

  • MRI

  • CT Scanners

• Therapeutic Devices

• Pacemakers

• Defibrillators

• Stents

• Heart Valves

• Catheters

• TAVR Systems

 

By Application

• Cardiac Surgery

• Diagnostic Imaging

• Coronary Artery Disease (CAD)

• Heart Valve Diseases

• Arrhythmia

 

By End-User

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Cardiology Clinics

• Home Care Settings

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Cardiovascular Devices Market Segment Analysis: Trends and Growth Patterns

By Type of Device:

Leading Segment: Diagnostic Devices (ECG, Holter Monitors, Echocardiography, MRI, CT Scanners)

The diagnostic devices segment holds the largest market share in the cardiovascular devices market, accounting for approximately 55% of the total market. This segment’s dominance is largely attributed to the increasing prevalence of cardiovascular diseases (CVDs) worldwide, which drives the demand for diagnostic tools to detect & monitor heart conditions. Among diagnostic devices, ECGs & echocardiography systems are the most widely used. The adoption of advanced diagnostic technologies such as MRI & CT scanners has also contributed to the segment's significant market share. Additionally, rising healthcare expenditures & improving healthcare infrastructure in emerging economies are further fueling the growth of diagnostic devices.

Fastest-Growing Segment: Therapeutic Devices (Pacemakers, Defibrillators, Stents, Heart Valves, Catheters, TAVR Systems)

The therapeutic devices segment is the fastest-growing in the cardiovascular devices market, with a projected CAGR of 8.1% from 2025 to 2030. This rapid growth can be attributed to advancements in minimally invasive techniques, such as Transcatheter Aortic Valve Replacement (TAVR) & the increasing demand for pacemakers, defibrillators & stents. The segment's growth is also propelled by the rising incidence of heart failure, arrhythmia & coronary artery disease (CAD), requiring more advanced therapeutic interventions. Technological innovations, such as bioresorbable stents & next-generation pacemakers, are expected to further drive growth in this segment.

 

By Application:

Leading Segment: Coronary Artery Disease (CAD)

Coronary artery disease (CAD) is the leading application segment in the cardiovascular devices market, contributing significantly to the overall market revenue. CAD treatments, including stents, coronary bypass surgery, and catheter-based interventions, remain in high demand due to the rising global prevalence of CAD. It is estimated that CAD accounts for more than 30% of all cardiovascular procedures performed globally. The growing elderly population, unhealthy lifestyle patterns & rising incidence of risk factors such as hypertension & obesity are key contributors to the dominance of CAD in the cardiovascular devices market.

Fastest-Growing Segment: Heart Valve Diseases

Heart valve diseases are the fastest-growing application segment, with a projected CAGR of 9.2% over the next five years. The growing demand for heart valve replacement procedures, such as those involving mechanical or bioprosthetic valves & the rise in minimally invasive surgeries like TAVR are driving this growth. As the global population ages, the incidence of heart valve diseases such as aortic stenosis is increasing, leading to greater demand for valve replacement and repair solutions. Additionally, advancements in TAVR technology are further accelerating the growth in this segment.

 

By End-User:

Leading Segment: Hospitals

Hospitals remain the leading end-user in the cardiovascular devices market, accounting for over 60% of the market share. This segment's dominance is due to the high number of cardiovascular surgeries, diagnostic procedures & emergency treatments conducted in hospitals. Advanced diagnostic & therapeutic devices, including stents, pacemakers, and defibrillators, are primarily used in hospital settings, particularly in cardiac care units & specialized cardiovascular departments. Hospitals are also the primary locations for complex procedures such as heart valve surgeries & catheterization.

Fastest-Growing Segment: Home Care Settings

The home care settings segment is the fastest-growing, with a projected CAGR of 10.5% from 2025 to 2030. The increasing trend toward home healthcare services, especially for elderly patients with chronic cardiovascular conditions, is driving this growth. The adoption of remote monitoring devices, such as portable ECG machines, wearable defibrillators & home-use blood pressure monitors, is on the rise. Healthcare systems' efforts to reduce hospital readmissions & provide continuous care in non-hospital environments are also contributing to the demand for cardiovascular devices in home care settings.

 

By Region:

Leading Region: North America

North America holds the largest market share in the cardiovascular devices market, contributing around 35% of the total revenue. The U.S. is a major contributor due to its well-established healthcare infrastructure, high healthcare expenditure & growing demand for advanced cardiovascular treatments. The prevalence of cardiovascular diseases in North America, driven by factors such as obesity, aging population & sedentary lifestyles, supports the demand for diagnostic and therapeutic cardiovascular devices. Ongoing advancements in medical technology & regulatory approvals for new devices are boosting the growth of the cardiovascular devices market in this region.

Fastest-Growing Region: Asia-Pacific

APAC is the fastest-growing region for cardiovascular devices, with a projected CAGR of 9.7% during the forecast period. The growing healthcare infrastructure in countries such as China, India & Japan is driving the demand for cardiovascular devices. The rising incidence of cardiovascular diseases, particularly in rapidly developing nations, is creating a significant need for diagnostic and therapeutic devices. Furthermore, increasing healthcare awareness, improving disposable incomes & government initiatives for healthcare access are contributing to the accelerated growth in this region. The rise in cardiovascular disease risk factors such as smoking, hypertension, and diabetes further supports the demand for cardiovascular solutions in Asia-Pacific.

 

Key Players in the Cardiovascular Devices Market

• Medtronic

• Abbott Laboratories

• Boston Scientific Corporation

• Edwards Lifesciences

• GE Healthcare

• Siemens Healthineers

• Philips Healthcare

• Terumo Corporation

• Johnson & Johnson (Biosense Webster)

• Biotronik

 

Cardiovascular Devices Market Report Coverage

Report Attribute	Details
Forecast Period	2023 – 2030
Market Size Value in 2023	USD 54.1 Billion
Revenue Forecast in 2030	USD 88.2 Billion
Overall Growth Rate	CAGR of 6.9%
Base Year for Estimation	2022
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2023 – 2030)
Segmentation	By Type of Device, By Application, By End-User, By Geography
By Type of Device	Diagnostic Devices (ECG, Holter Monitors, Echocardiography, MRI, CT Scanners); Therapeutic Devices (Pacemakers, Defibrillators, Stents, Heart Valves, Catheters, TAVR Systems)
By Application	Cardiac Surgery, Diagnostic Imaging, Coronary Artery Disease (CAD), Heart Valve Diseases, Arrhythmia
By End-User	Hospitals, Ambulatory Surgical Centers (ASCs), Cardiology Clinics, Home Care Settings
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, China, India, etc.
Pricing and Purchase Options	Customized options available

 

Recent Developments

• In February 2025, Boston Scientific introduced the POLARx Cryoablation System for treating atrial fibrillation, improving procedural efficiency and patient safety.

• In January 2025, Medtronic launched the Micra AV2, the world's smallest leadless pacemaker with extended battery life.

• In December 2024, Abbott Laboratories received FDA approval for its minimally invasive Tendyne Mitral Valve Replacement System.

• In June 2024, AliveCor announced dual FDA clearance for its Kardia 12L ECG System, an advanced electrocardiogram device capable of delivering 35 cardiac determinations, enhancing diagnostic capabilities for healthcare providers.

• In April 2024, Abiomed's Impella Bridge-to-Recovery (BTR) minimally-invasive heart pump has successfully been implanted in the first patient as part of an early feasibility study. This milestone represents a major advancement in heart failure treatment options.

 

Future Outlook

The future outlook for the Cardiovascular Devices Market is highly promising, driven by technological advancements, increasing adoption of AI-powered diagnostics & the growing demand for minimally invasive procedures. Remote monitoring solutions, wearable ECG devices, and AI-integrated cardiac imaging systems will revolutionize early detection and management of heart conditions. Additionally, biodegradable stents, leadless pacemakers & robotic-assisted cardiac surgeries will shape the next wave of innovation. However, stringent regulatory approvals and high device costs remain key challenges. Emerging markets in APAC & Latin America will present significant growth opportunities, as healthcare infrastructure improves & government initiatives support advanced cardiac care accessibility. Overall, the cardiovascular devices industry is set to expand rapidly, enhancing patient outcomes through cutting-edge medical innovations & personalized treatment approaches.